Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Treasury Shares (2022 - 2025)

Kezar Life Sciences' Treasury Shares history spans 4 years, with the latest figure at $1127.0 for Q3 2025.

  • For Q3 2025, Treasury Shares fell 89.8% year-over-year to $1127.0; the TTM value through Sep 2025 reached $1127.0, down 89.8%, while the annual FY2024 figure was $10916.0, 95.03% down from the prior year.
  • Treasury Shares for Q3 2025 was $1127.0 at Kezar Life Sciences, down from $8318.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $483276.0 in Q1 2023 and bottomed at $1127.0 in Q3 2025.
  • The 4-year median for Treasury Shares is $41935.0 (2022), against an average of $174870.8.
  • The largest annual shift saw Treasury Shares surged 1052.44% in 2023 before it plummeted 96.37% in 2024.
  • A 4-year view of Treasury Shares shows it stood at $434790.0 in 2022, then plummeted by 94.95% to $21945.0 in 2023, then crashed by 50.26% to $10916.0 in 2024, then crashed by 89.68% to $1127.0 in 2025.
  • Per Business Quant, the three most recent readings for KZR's Treasury Shares are $1127.0 (Q3 2025), $8318.0 (Q2 2025), and $8451.0 (Q1 2025).